• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测前驱症状个体向帕金森病转化的脑结构磁共振成像标志物。

Brain structural MRI marker for predicting conversion to Parkinson's disease in individuals with prodromal symptoms.

作者信息

Park Chang-Hyun, Yoon Uicheul, Lee Phil Hyu, Kim Jinna, Lee Seung-Koo, Shin Na-Young

机构信息

Division of Artificial Intelligence and Software, College of Artificial Intelligence, Ewha Womans University, Seoul, Republic of Korea.

Department of Biomedical Engineering, College of Bio and Medical Sciences, Daegu Catholic University, Gyeongsan, Republic of Korea.

出版信息

Front Aging Neurosci. 2025 Jul 16;17:1579326. doi: 10.3389/fnagi.2025.1579326. eCollection 2025.

DOI:10.3389/fnagi.2025.1579326
PMID:40741046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12307297/
Abstract

BACKGROUND

During the prodromal stage of Parkinson's disease (PD), brain structural alterations precede clinical diagnosis and offer opportunities for early detection. We investigated whether combining clinical non-motor markers with an MRI-based brain structural marker could enhance predictive performance for PD conversion.

METHODS

Individuals with prodromal symptoms ( = 46, 63.5 ± 7.6 years, 24 males) were selected from the Parkinson's Progression Markers Initiative dataset. We developed a machine learning classifier to identify individuals with brain structural patterns similar to PD based on cortical thickness and white matter integrity. Its predictive performance for PD conversion was assessed alone and combined with clinical non-motor markers such as rapid eye movement sleep behavior disorder and olfactory dysfunction.

RESULTS

Six individuals converted to PD within 4 years. The MRI marker classified 21 individuals as having PD-like brain patterns, including all six converters. When combined with olfactory dysfunction, the approach achieved optimal performance with 100% sensitivity, 80% specificity, and 90% balanced accuracy, outperforming individual markers and other combinations.

CONCLUSION

MRI-quantified brain structural similarity to PD, particularly when combined with olfactory assessment, significantly enhances prediction of PD conversion in individuals with prodromal symptoms. This accessible, multimodal approach could facilitate early identification of high-risk individuals for targeted interventions and clinical trials.

摘要

背景

在帕金森病(PD)的前驱期,脑结构改变先于临床诊断出现,为早期检测提供了机会。我们研究了将临床非运动标志物与基于MRI的脑结构标志物相结合是否能提高对PD转化的预测性能。

方法

从帕金森病进展标志物计划数据集中选取有前驱症状的个体(n = 46,63.5±7.6岁,24名男性)。我们开发了一种机器学习分类器,根据皮质厚度和白质完整性来识别具有与PD相似脑结构模式的个体。分别评估其对PD转化的预测性能,以及与快速眼动睡眠行为障碍和嗅觉功能障碍等临床非运动标志物相结合时的预测性能。

结果

4年内有6名个体转化为PD。MRI标志物将21名个体分类为具有类似PD的脑模式,其中包括所有6名转化者。当与嗅觉功能障碍相结合时,该方法达到了最佳性能,灵敏度为100%,特异度为80%,平衡准确度为90%,优于单个标志物及其他组合。

结论

MRI量化的与PD相似的脑结构,特别是与嗅觉评估相结合时,能显著提高对有前驱症状个体PD转化的预测。这种易于采用的多模态方法有助于早期识别高危个体,以进行有针对性的干预和临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3f0/12307297/bbf0f48b0b15/fnagi-17-1579326-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3f0/12307297/8cd12837be8e/fnagi-17-1579326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3f0/12307297/ab8db72bdab7/fnagi-17-1579326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3f0/12307297/bbf0f48b0b15/fnagi-17-1579326-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3f0/12307297/8cd12837be8e/fnagi-17-1579326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3f0/12307297/ab8db72bdab7/fnagi-17-1579326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3f0/12307297/bbf0f48b0b15/fnagi-17-1579326-g003.jpg

相似文献

1
Brain structural MRI marker for predicting conversion to Parkinson's disease in individuals with prodromal symptoms.用于预测前驱症状个体向帕金森病转化的脑结构磁共振成像标志物。
Front Aging Neurosci. 2025 Jul 16;17:1579326. doi: 10.3389/fnagi.2025.1579326. eCollection 2025.
2
Utility of a newly created questionnaire on subtle motor symptoms in high-risk subjects with Parkinson's disease.一份新创建的关于帕金森病高危受试者细微运动症状的问卷的效用。
J Parkinsons Dis. 2025 Jul 27:1877718X251361506. doi: 10.1177/1877718X251361506.
3
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder.不同的脑萎缩进展亚型是孤立性快速眼动睡眠行为障碍中表型转换的基础。
EBioMedicine. 2025 May 29;117:105753. doi: 10.1016/j.ebiom.2025.105753.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Machine learning-based brain magnetic resonance imaging radiomics for identifying rapid eye movement sleep behavior disorder in Parkinson's disease patients.基于机器学习的脑磁共振成像放射组学用于识别帕金森病患者的快速眼动睡眠行为障碍
BMC Med Imaging. 2025 Jul 1;25(1):227. doi: 10.1186/s12880-025-01748-4.
6
Unveiling the neural network of freezing of gait in Parkinson's disease: A coordinate-based network study.揭示帕金森病步态冻结的神经网络:一项基于坐标的网络研究。
J Parkinsons Dis. 2025 Jun 19:1877718X251348669. doi: 10.1177/1877718X251348669.
7
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
8
Early detection of Parkinson's disease: Machine learning-based prediction of UPDRS Part III scores in patients using smartphone assessments.帕金森病的早期检测:基于机器学习通过智能手机评估预测患者的统一帕金森病评定量表第三部分得分
J Parkinsons Dis. 2025 Jul 28:1877718X251359494. doi: 10.1177/1877718X251359494.
9
A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.一种用于帕金森病灵敏且准确诊断的微创生物标志物。
medRxiv. 2024 Jun 30:2024.06.29.24309703. doi: 10.1101/2024.06.29.24309703.
10
Decline of olfactory function in Parkinson's disease: A ten-year longitudinal study.帕金森病嗅觉功能减退:一项十年纵向研究。
J Parkinsons Dis. 2024 Oct 15;14(7):1877718X241298708. doi: 10.1177/1877718X241298708. Epub 2024 Nov 1.

本文引用的文献

1
Multimodal neuroimaging-based prediction of Parkinson's disease with mild cognitive impairment using machine learning technique.基于多模态神经影像学,运用机器学习技术对帕金森病伴轻度认知障碍进行预测。
NPJ Parkinsons Dis. 2024 Nov 11;10(1):218. doi: 10.1038/s41531-024-00828-6.
2
Aberrant corticospinal tract characteristics in prodromal PD: A diffusion tensor imaging study.前驱期帕金森病中皮质脊髓束的异常特征:一项扩散张量成像研究。
Clin Park Relat Disord. 2022 Dec 19;8:100182. doi: 10.1016/j.prdoa.2022.100182. eCollection 2023.
3
Simulating the progression of brain structural alterations in Parkinson's disease.
模拟帕金森病脑结构改变的进展
NPJ Parkinsons Dis. 2022 Jun 28;8(1):86. doi: 10.1038/s41531-022-00349-0.
4
Multi-modality machine learning predicting Parkinson's disease.多模态机器学习预测帕金森病。
NPJ Parkinsons Dis. 2022 Apr 1;8(1):35. doi: 10.1038/s41531-022-00288-w.
5
Prodromal Parkinson's disease: hype or hope for disease-modification trials?前驱期帕金森病:是疾病修饰试验的炒作还是希望?
Transl Neurodegener. 2022 Feb 21;11(1):11. doi: 10.1186/s40035-022-00286-1.
6
Alteration of brain structural connectivity in progression of Parkinson's disease: A connectome-wide network analysis.帕金森病进展过程中脑结构连接的改变:连接组网络分析。
Neuroimage Clin. 2021;31:102715. doi: 10.1016/j.nicl.2021.102715. Epub 2021 Jun 6.
7
Update of the MDS research criteria for prodromal Parkinson's disease.前驱帕金森病 MDS 研究标准的更新。
Mov Disord. 2019 Oct;34(10):1464-1470. doi: 10.1002/mds.27802. Epub 2019 Aug 14.
8
Increased Cortical Thickness in Attentional Networks in Parkinson's Disease with Minor Hallucinations.轻度幻觉型帕金森病患者注意力网络中皮质厚度增加。
Parkinsons Dis. 2019 May 2;2019:5351749. doi: 10.1155/2019/5351749. eCollection 2019.
9
Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.黑质小体成像和神经黑色素敏感MRI在帕金森综合征诊断评估中的应用
Mov Disord Clin Pract. 2018 Feb 22;5(2):131-140. doi: 10.1002/mdc3.12590. eCollection 2018 Mar-Apr.
10
Advances in markers of prodromal Parkinson disease.前驱期帕金森病标志物的研究进展。
Nat Rev Neurol. 2016 Oct 27;12(11):622-634. doi: 10.1038/nrneurol.2016.152.